Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by KH Krause
First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine
Retrovirology
Virology
Infectious Diseases
Related publications
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus Lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine in Healthy Females
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Differential Immunogenicity of Vaccinia and HIV-1 Components of a Human Recombinant Vaccine in Mucosal and Blood Compartments
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C Gag Vaccine in Healthy HIV-1-Uninfected Adults
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial
The Lancet
Medicine
Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Modeling Pre-Existing Immunity to Adenovirus in Rodents: Immunological Requirements for Successful Development of a Recombinant Adenovirus Serotype 5-Based Ebola Vaccine
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
